ENDOPUMP
The new generation of therapy for Parkinson
Health Tech & Life Sciences
Non Active, May 2022 ceased to operate
Company Overview
Snapshot
Founded in January 2019 by Prof. Moussa Youdim, Tal Youdim, Oded Meiri, and Prof. Eliyahu Heldman, ENDOPUMP operates with 1–10 employees. The company secured its seed funding in January 2019, with Youdim Pharmaceuticals participating as an investor.
Business overview
ENDOPUMP is a Health Tech & Life Sciences company focused on developing new generation therapies for Parkinson's disease. Operating in the Pharmaceuticals sector, the company is currently in the R&D product stage, targeting the B2B market with its therapeutic solutions.
Company Intelligence Q&A
- What is ENDOPUMP's primary focus?
- ENDOPUMP is dedicated to developing new generation therapies for Parkinson's disease, operating within the Health Tech & Life Sciences sector.
- When was ENDOPUMP founded and by whom?
- ENDOPUMP was founded in January 2019 by Prof. Moussa Youdim, Tal Youdim, Oded Meiri, and Prof. Eliyahu Heldman.
- What is the current status of ENDOPUMP?
- ENDOPUMP is currently non-active, having ceased operations in May 2022.
- Which investor participated in ENDOPUMP's funding round?
- In January 2019, Youdim Pharmaceuticals participated as an investor in ENDOPUMP's seed funding round.
- What is ENDOPUMP's current product development stage?
- ENDOPUMP's products are currently in the R&D stage, focusing on developing new generation therapies for Parkinson's disease, targeting the B2B market.